Feedback (FDBK)

Sector:

Health Care

Index:

FTSE AIM All-Share

 20.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 140.00
  • 52 Week Low: 19.50
  • Currency: UK Pounds
  • Shares Issued: 13.33m
  • Volume: 4,973
  • Market Cap: £2.73m
  • RiskGrade: 267
  • Beta: 0.43

Feedback secures funding to extend Oldham CDC pilot

By Josh White

Date: Monday 02 Sep 2024

LONDON (ShareCast) - (Sharecast News) - Clinical infrastructure specialist Feedback announced the securing of further funding on Monday, to extend its Community Diagnostic Centre (CDC) pathway pilot at the Northern Care Alliance NHS Foundation Trust (NCA) site in Oldham.
The AIM-traded firm said the additional funding, totalling £69,000, would support the continuation of the pilot through to 31 March 2025.

It said the funding came from the 2024-2025 NHS England budget, with an initial 50% already allocated from the first half budget, covering the period up to 30 September.

The remaining balance was expected from the second half budget.

Feedback said the pilot, focusing on breathlessness, aimed to demonstrate the effectiveness of a pathway approach in improving CDC utilisation and reducing patient wait times, contributing valuable data to support further expansion and funding.

Additionally, the use of Feedback's Bleepa digital referral system at the NCA had significantly expanded since December.

Initially supporting six specialities at Oldham and one at Fairfield General Hospital, the system now covered 11 specialities at Oldham, including endocrinology and haematology, and five at Fairfield, including cardiology and respiratory.

The board said the number of users increased by 68% between June 2023 and June 2024, with over 1,400 users generating more than 9,200 patient referrals in the period.

A report by Unity Insights, published in October last year, highlighted that NCA experienced a dramatic reduction in clinical response times after switching from paper-based to Bleepa digital referrals.

The report estimated that the time savings could be worth £0.82m to the NCA over five years, with potential savings of £7.7m if the system were adopted across the Greater Manchester Integrated Care Board.

"We are extremely pleased to announce the confirmation of the funded second stage of our CDC pilot at Oldham and remain focussed on delivering further evidence that supports the adoption of a pathway approach for CDCs, enabled by the Bleepa platform," said chief executive officer Tom Oakley.

"We see this as further validation of the value the NCA and NHSE sees in our service and will use our findings to support national expansion.

"As use of our digital inpatient referral system expands to cover more specialities, more users and capture more referrals at Oldham and Fairfield, we are eager to build upon the positive findings from Unity's report and deliver much needed time savings to the NHS."

At 0821 BST, shares in Feedback were up 1.62% at 55.89p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Feedback Market Data

Currency UK Pounds
Share Price 20.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 140.00
52 Week Low 19.50
Volume 4,973
Shares Issued 13.33m
Market Cap £2.73m
Beta 0.43
RiskGrade 267

Feedback Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
22.85% above the market average22.85% above the market average22.85% above the market average22.85% above the market average22.85% above the market average
88.57% above the sector average88.57% above the sector average88.57% above the sector average88.57% above the sector average88.57% above the sector average
Price Trend
91.93% below the market average91.93% below the market average91.93% below the market average91.93% below the market average91.93% below the market average
89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average
Income Not Available
Growth
45.59% above the market average45.59% above the market average45.59% above the market average45.59% above the market average45.59% above the market average
77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Feedback Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
11:22 9 @ 20.00p
11:21 9 @ 20.90p
08:12 4,955 @ 20.00p

Feedback Key Personnel

CEO Tom Oakley
CFO Anesh Patel

Top of Page